Cambridge Investment Research Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,447	Closed	-$252K	–	2557
2019 Q4	$252K	Sell	5,447 -512	-9%	-$22.2K	﹤0.01%	2029
2019 Q3	$243K	Buy	5,959 +549	+10%	+$23.7K	﹤0.01%	1981
2019 Q2	$260K	Buy	5,410 +1,536	+40%	+$80.7K	﹤0.01%	1839
2019 Q1	$243K	Buy	+3,874	New	+$266K	﹤0.01%	1945
2018 Q4	–	Sell	-3,278	Closed	-$211K	–	2362
2018 Q3	$211K	Buy	+3,278	New	+$183K	﹤0.01%	2024
2017 Q4	–	Sell	-8,728	Closed	-$288K	–	2204
2017 Q3	$288K	Sell	8,728 -1,633	-16%	-$56.6K	﹤0.01%	1574
2017 Q2	$347K	Buy	+10,361	New	+$309K	0.01%	1426

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cambridge Investment Research Advisors's BEAT Position: Q1 2020 in Review

Cambridge Investment Research Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 5,447 shares — an estimated $252K sold.

Cambridge Investment Research Advisors first reported a position in BEAT in Q2 2017 and held it in 7 quarters. The position peaked at $347K in Q2 2017. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Cambridge Investment Research Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
Cambridge Investment Research Advisors sold 5,447 BioTelemetry, Inc. shares in Q1 2020, an estimated $252K.
Cambridge Investment Research Advisors first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 7 quarters.
Cambridge Investment Research Advisors's BioTelemetry, Inc. position peaked at $347K in Q2 2017.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2020, filed 8 May 2020.